Company to host analyst call at 5:00pm ET today to discuss progress to date and expansion of clinical trial SOUTH SAN ...
Company to host analyst call at 5:00pm ET today to discuss progress to date and expansion of clinical trial SOUTH SAN FRANCISCO, Calif, Jan. 07, 2026 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, ...
The Food and Drug Administration has approved Yartemlea ® (narsoplimab-wuug) for the treatment of adult and pediatric patients aged 2 years and older with hematopoietic stem cell transplant ...
HED Secretary Ghulam Fareed Kathia told Dawn that a four-member committee - three vice chancellors (two of public sector ...
19hon MSN
A CT hospital is expanding a program that is saving lives. Here’s how it works, why it was adopted
Use of whole blood products to save egregiously injured U.S. military combatants became a practice during wars in Iraq and ...
The trial met its primary endpoint with a hazard ratio of 0.75, indicating a significant reduction in disease progression ...
Aplastic anaemia is a rare and potentially life-threatening condition that can worsen during pregnancy. Its management poses unique challenges due to risks of haemorrhage, infection and transfusion ...
The American Red Cross is teetering on a blood shortage this winter, which could lead to a disruption in lifesaving care.The ...
Hyderabad: The blood bank at Nizam’s Institute of Medical Sciences (NIMS) has recorded its highest-ever annual blood ...
The American Red Cross is teetering on a blood shortage this winter, which could lead to a disruption in lifesaving care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback